http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106478766-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
filingDate | 2015-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106478766-B |
titleOfInvention | Anti- handle purple sesame terpenoid and preparation method and application |
abstract | A kind of anti-handle purple sesame terpenoid and its pharmaceutical composition and its application in the medicine or health food for preparing treatment renal fibrosis are provided.Activity research shows that the compound and pharmaceutical composition can suppress people's renal cells generation extracellular matrix (FTN of the inductions of TGF β 1, fibronectin), in view of the index is one of main performance of renal fibrosis pathology, it is closely related with clinical disease, therefore show that there is the compounds of this invention anti-renal fibrosis to act on, can be used to treat the diseases such as renal fibrosis. |
priorityDate | 2015-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.